Jaaks, Patricia
Coker, Elizabeth A.
Vis, Daniel J.
Edwards, Olivia http://orcid.org/0000-0001-8753-9348
Carpenter, Emma F. http://orcid.org/0000-0002-1911-6842
Leto, Simonetta M. http://orcid.org/0000-0001-7580-6584
Dwane, Lisa
Sassi, Francesco
Lightfoot, Howard
Barthorpe, Syd
van der Meer, Dieudonne
Yang, Wanjuan
Beck, Alexandra
Mironenko, Tatiana
Hall, Caitlin http://orcid.org/0000-0002-5713-5980
Hall, James http://orcid.org/0000-0002-8124-5434
Mali, Iman
Richardson, Laura http://orcid.org/0000-0002-8075-3816
Tolley, Charlotte http://orcid.org/0000-0002-1119-7983
Morris, James
Thomas, Frances http://orcid.org/0000-0003-2345-0912
Lleshi, Ermira
Aben, Nanne
Benes, Cyril H.
Bertotti, Andrea
Trusolino, Livio http://orcid.org/0000-0002-6379-3365
Wessels, Lodewyk http://orcid.org/0000-0002-1656-6995
Garnett, Mathew J. http://orcid.org/0000-0002-2618-4237
Article History
Received: 2 July 2021
Accepted: 18 January 2022
First Online: 23 February 2022
Competing interests
: M.J.G. has received research grants from AstraZeneca, GlaxoSmithKline, and Astex Pharmaceuticals, and is founder of Mosaic Therapeutics. C.H.B is an employee of Novartis and previously received research funding from Novartis. L.T. reports research grants from Symphogen, Servier, Pfizer, Menarini, Merck KGaA and Merus. Drug combinations described in this study are subject to patents filed by Genome Research Limited, which is the name under which the Sanger Institute operates.